Seladelpar

PHILADELPHIA — In this video, Nancy S. Reau, MD, FAASLD, AGAF, highlights a presentation at the ACG Annual Scientific Meeting investigating the use of Livdelzi in patients with primary biliary cholangitis and cirrhosis.

Recent advancements have been made in the treatment of primary biliary cholangitis, particularly for patients who do not respond adequately to first-line treatment.

WASHINGTON — Seladelpar use led to “rapid, marked and sustained improvement” in markers of cholestasis and liver injury among patients with primary biliary cholangitis, according to interim results of the ongoing, phase 3 ASSURE study.

In these videos, James Boyer, MD, FACEP, Ensign Professor of Medicine and Emeritus Director of the Liver Center at Yale School of Medicine discusses the current understanding of the genetic and environmental factors that can contribute to biliary diseases.

In these videos, James Boyer, MD, FACEP, Ensign Professor of Medicine and Emeritus Director of the Liver Center at Yale School of Medicine discusses the challenges that exist in diagnosing biliary diseases.

In these videos, James Boyer, MD, FACEP, Ensign Professor of Medicine and Emeritus Director of the Liver Center at Yale School of Medicine discusses the latest treatments for biliary diseases

In these videos, James Boyer, MD, FACEP, Ensign Professor of Medicine and Emeritus Director of the Liver Center at Yale School of Medicine discusses the current understanding of the genetic and environmental factors that can contribute to biliary diseases.

In these videos, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease at the University of Toronto, discusses the latest advancements in the treatment of biliary diseases.

In these videos, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease at the University of Toronto, discusses the latest advancements in the treatment of biliary diseases.

In these videos, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease at the University of Toronto, discusses the latest advancements in the treatment of biliary diseases.